Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mennat Gharib

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
STAR Protocols|March 31, 2021
An updated protocol for the cost-effective and weekend-free culture of human induced pluripotent stem cellsDavi Marco Lyra-Leite, Hananeh Fonoudi, Mennat Gharib, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Machine Learning Resolves Functional Phenotypes and Therapeutic Responses in KCNQ2 Developmental Epileptic Encephalopathy iPSC ModelsDina Simkin, Syed M A Wafa, Mennat Gharib, et al.
Trends in Pharmacological Sciences|April 15, 2022
'Channeling' therapeutic discovery for epileptic encephalopathy through iPSC technologiesDina Simkin, Christina Ambrosi, Kelly A Marshall, et al.
JACC. Cardiooncology|March 21, 2024
Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related GenesHananeh Fonoudi, Mariam Jouni, Romina B Cejas, et al.
Stem Cell Reports|June 14, 2023
Nutritional requirements of human induced pluripotent stem cellsDavi M Lyra-Leite, Raymond R Copley, Phillip P Freeman, et al.
Circulation|December 7, 2021
Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced CardiotoxicityTarek Magdy, Mariam Jouni, Hui-Hsuan Kuo, et al.
Cell Stem Cell|September 15, 2021
RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapyTarek Magdy, Zhengxin Jiang, Mariam Jouni, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
STAR Protocols|March 31, 2021
An updated protocol for the cost-effective and weekend-free culture of human induced pluripotent stem cellsDavi Marco Lyra-Leite, Hananeh Fonoudi, Mennat Gharib, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Machine Learning Resolves Functional Phenotypes and Therapeutic Responses in KCNQ2 Developmental Epileptic Encephalopathy iPSC ModelsDina Simkin, Syed M A Wafa, Mennat Gharib, et al.
Trends in Pharmacological Sciences|April 15, 2022
'Channeling' therapeutic discovery for epileptic encephalopathy through iPSC technologiesDina Simkin, Christina Ambrosi, Kelly A Marshall, et al.
JACC. Cardiooncology|March 21, 2024
Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related GenesHananeh Fonoudi, Mariam Jouni, Romina B Cejas, et al.
Stem Cell Reports|June 14, 2023
Nutritional requirements of human induced pluripotent stem cellsDavi M Lyra-Leite, Raymond R Copley, Phillip P Freeman, et al.
Circulation|December 7, 2021
Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced CardiotoxicityTarek Magdy, Mariam Jouni, Hui-Hsuan Kuo, et al.
Cell Stem Cell|September 15, 2021
RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapyTarek Magdy, Zhengxin Jiang, Mariam Jouni, et al.
Pageof 1